Tristel plc
("Tristel", the "Company" or the "Group")
Notice of Results
Investor briefing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that its preliminary results for the year ended 30 June 2022 will be announced on Tuesday 25 October 2022.
Investor presentation
Paul Swinney , CEO, and Liz Dixon, CFO, will provide a live hybrid presentation relating to the Company's preliminary results on Tuesday 25 October 2022 at 4:30pm, which is open to all existing and potential shareholders.
For those attending in-person, the Company welcome them to N o.1 Cornhill, London, EC3V 3ND from 4.15pm for a 4.30pm start. If you would like to register to attend for the in-person presentation, please contact Walbrook PR on 020 7933 8780 or email tristel@walbrookpr.com .
For those that are unable to attend in-person, a live webcast of the investor briefing will be streamed via the Investor Meet Company platform. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Tristel plc to register for the presentation via: https://www.investormeetcompany.com/tristel-plc/register-investor
The results presentation will be made available on the Company's website on the day of results - www.tristelgroup.com
For further information please contact:
Tristel plc |
Tel: 01638 721 500 |
|
Paul Swinney, Chief Executive Officer |
|
|
Liz Dixon, Chief Financial Officer |
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Applegarth |
Mob: 07584 391 303 |
|
|
|
|
finnCap |
Tel: 020 7220 0500 |
|
Geoff Nash/ Charlie Beeson (Corporate Finance) |
|
|
A lice Lane (ECM) |
|
|